Price
Frequently asked questions
What is API's market capitalization?
The market capitalization of API is $480.34M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is API's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for API is 614.75. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for API?
API's Earnings Per Share (EPS) over the trailing twelve months (TTM) is 0.001586. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for API's stock?
Currently, 2 analysts cover API's stock, with a consensus target price of $0.994. Analyst ratings provide insights into the stock's expected performance.
What is API's revenue over the trailing twelve months?
Over the trailing twelve months, API reported a revenue of $2.60B.
What is the EBITDA for API?
API's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $61.18M. EBITDA measures the company's overall financial performance.
What is the free cash flow of API?
API has a free cash flow of $5.66M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
What is the 5-year beta of API's stock?
The 5-year beta for API is 0.35. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.
How many employees does API have, and what sector and industry does it belong to?
API employs approximately 5,105 people. It operates in the Consumer Staples sector, specifically within the Major Drugs industry.
What is the free float of API's shares?
The free float of API is 378.61M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
Market Cap
$480.34M5Y beta
0.35EPS (TTM)
0.001586Free Float
378.61MP/E ratio (TTM)
614.75Revenue (TTM)
$2.60BEBITDA (TTM)
$61.18MFree Cashflow (TTM)
$5.66MAnalyst Ratings
The price target is $0.994 and the stock is covered by 2 analysts.
Buy
1
Hold
1
Sell
0
Information
Australian Pharmaceutical Industries Pty Ltd is an Australia-based company. The Company provides services to the pharmacy industry. The Company services include health services, administering flu vaccinations, wholesale product delivery, retail services, electronic prescriptions or e-scripts through an electronic message, and provides health information.
5,105
Major Drugs
Consumer Staples
Identifier
ISIN
AU000000API4
Primary Ticker
GIW